PD04.01. Multimodal Treatment Strategies Incorporating Conversion Therapy for Thoracic Esophageal Cancer With Adjacent Organ Invasion

Clicks: 20
ID: 325930
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #186 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer Background Management of thoracic esophageal cancer with suspected adjacent organ invasion remains challenging because of diagnostic uncertainty and limited curative options. Recent advances in induction chemotherapy, including DCF and immune checkpoint inhibitors, have enabled downstaging and subsequent conversion to curative-intent treatment in selected patients. Methods We retrospectively reviewed 57 patients with locally advanced, initially unresectable thoracic esophageal squamous cell carcinoma without distant metastasis except supraclavicular lymph nodes, who initiated treatment with induction chemotherapy (DCF or immune checkpoint inhibitor plus chemotherapy) or definitive chemoradiotherapy between January 2014 and December 2024. Patients achieving complete response after non-surgical treatment or R0 resection were defined as cancer free. Cases diagnosed before the 12th edition of the Japanese Classification of Esophageal Cancer were reclassified as cT3br or cT4 based on endoscopic circumferential involvement and computed tomography findings, including compression or displacement of adjacent organs. Treatment pathways, conversion therapy, short-term surgical outcomes, and survival were analyzed. Results The cohort included 34 cT3br and 23 cT4 patients. Initial induction chemotherapy achieved downstaging to resectable disease in 85% of cT3br and 57% of cT4 cases. Conversion surgery was performed in 27 patients, with R0 resection achieved in 25. Median blood loss was 190 mL, operative time 524 minutes, and no in-hospital mortality occurred. Cancer-free status was associated with significantly improved survival in both cT3br and cT4 groups (2-year overall survival: 74% vs 11% and 100% vs 7%, respectively; both p<0.001). Among surgical cases, patients achieving pathological response grade ≥2 showed superior survival compared with non-responders (2-year overall survival: 100% vs 53%, p=0.01). Prognosis did not differ according to the invaded organ. Conclusion In thoracic esophageal cancer with adjacent organ invasion, achieving cancer-free status is strongly associated with improved survival regardless of initial T classification. A multimodal treatment strategy incorporating induction therapy and conversion treatment, including definitive chemoradiotherapy or surgery, represents a feasible curative approach. Careful treatment selection remains essential given the limitations of diagnostic accuracy in assessing organ invasion.
Reference Key
openalex_W7203985536 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.096
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.